Fulphila Subcutaneous and Larotrectinib Capsules
Determining the interaction of Fulphila Subcutaneous and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegfilgrastim
Brand name: Fulphila, Neulasta, Neulasta Onpro Kit, Udenyca, Neulasta Delivery Kit
Synonyms: Fulphila, Fulphila Injection
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fulphila Subcutaneous-Larotrectinib Oral Solution
- Fulphila Subcutaneous-Larotrectinib Sulfate
- Fulphila Subcutaneous-Lartruvo
- Fulphila Subcutaneous-Larynex
- Fulphila Subcutaneous-Laryng-O-Jet
- Fulphila Subcutaneous-Laryngesic
- Larotrectinib Capsules-Fulvestrant
- Larotrectinib Capsules-Fulvestrant Injection
- Larotrectinib Capsules-Fulvestrant Intramuscular
- Larotrectinib Capsules-Fulvicin P/G
- Larotrectinib Capsules-Fulvicin-U/F
- Larotrectinib Capsules-Fung-O Topical